GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Mycenax Biotech 4726.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

20.95

+1.21%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 740.2m

FY2016FY2025

Net income

−TWD 448.6m

FY2016FY2025

Free cash flow

−TWD 126.3m

FY2016FY2025

Shareholders' equity

TWD 1.60bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 740.2mTWD 683.9mTWD 652.6mTWD 732.3mTWD 774.3mTWD 665.3mTWD 390.8mTWD 211.4mTWD 318.6mTWD 200.6m
Research and developmentTWD 75.9mTWD 78.2mTWD 75.8mTWD 144.0mTWD 96.1mTWD 46.5mTWD 284.6mTWD 276.1mTWD 195.5mTWD 217.8m
Operating income−TWD 423.6m−TWD 448.2m−TWD 674.4m−TWD 447.4m−TWD 92.5mTWD 46.3m−TWD 229.2m−TWD 320.9m−TWD 121.5m−TWD 218.4m
Net income−TWD 448.6m−TWD 467.1m−TWD 682.8m−TWD 453.6m−TWD 89.9mTWD 30.9m−TWD 218.2m−TWD 274.4m−TWD 188.4m−TWD 158.5m
Diluted earnings per share-2.16-2.27-3.32-2.21-0.590.24-1.98-2.50-1.71-1.45

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 3.26bnTWD 3.37bnTWD 3.77bnTWD 4.45bnTWD 3.14bnTWD 1.75bnTWD 1.41bnTWD 1.12bnTWD 1.31bnTWD 1.39bn
Cash and short-term investments—————————TWD 812.9m
Total liabilitiesTWD 1.66bnTWD 1.34bnTWD 1.32bnTWD 1.35bnTWD 1.23bnTWD 540.9mTWD 306.0mTWD 211.7mTWD 168.9mTWD 73.2m
DebtTWD 433.7mTWD 883.4mTWD 726.3mTWD 955.9mTWD 744.6mTWD 196.6mTWD 46.8m———
Shareholders' equityTWD 1.60bnTWD 2.02bnTWD 2.45bnTWD 3.11bnTWD 1.91bnTWD 1.21bnTWD 1.10bnTWD 907.0mTWD 1.14bnTWD 1.32bn
Shares outstanding207m206m206m205m153m128m110m110m110m110m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 27.2m−TWD 191.7m−TWD 131.2m−TWD 150.2m−TWD 146.2mTWD 174.2m−TWD 140.7m−TWD 180.3m−TWD 45.5m−TWD 158.4m
Capital spending−TWD 99.1m−TWD 330.5m−TWD 297.6m−TWD 626.9m−TWD 1.10bn−TWD 260.2m−TWD 177.9m−TWD 118.5m−TWD 91.5m−TWD 110.0m
Free cash flow−TWD 126.3m−TWD 522.2m−TWD 428.8m−TWD 777.1m−TWD 1.24bn−TWD 86.0m−TWD 318.7m−TWD 298.7m−TWD 137.1m−TWD 268.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 203.1mTWD 196.8mTWD 284.6mTWD 131.4mTWD 202.6mTWD 121.7mTWD 194.0mTWD 209.1m
Operating income−TWD 76.9m−TWD 111.5m−TWD 47.2m−TWD 119.9m−TWD 133.7m−TWD 122.7m−TWD 91.7m−TWD 137.5m
Net income−TWD 82.6m−TWD 117.0m−TWD 52.4m−TWD 129.9m−TWD 137.2m−TWD 129.1m−TWD 83.3m−TWD 146.6m
Diluted earnings per share-0.40-0.56-0.25-0.63-0.66-0.62-0.40-0.71
Cash from operationsTWD 111.0m−TWD 26.0mTWD 87.0m−TWD 50.0m−TWD 78.0mTWD 14.0m−TWD 55.0mTWD 6.0m
Capital spending−TWD 5.0m−TWD 92.0m−TWD 23.0m−TWD 24.0m—−TWD 84.0m−TWD 47.0m−TWD 60.0m
Free cash flowTWD 106.0m−TWD 118.0mTWD 64.0m−TWD 74.0m—−TWD 70.0m−TWD 102.0m−TWD 54.0m
Total assetsTWD 3.28bnTWD 3.34bnTWD 3.26bnTWD 3.33bnTWD 3.21bnTWD 3.34bnTWD 3.37bnTWD 3.48bn
DebtTWD 335.4mTWD 384.5mTWD 433.7mTWD 482.8mTWD 531.9mTWD 581.1mTWD 611.4mTWD 659.1m
Shareholders' equityTWD 1.41bnTWD 1.49bnTWD 1.60bnTWD 1.64bnTWD 1.77bnTWD 1.90bnTWD 2.02bnTWD 2.10bn

Financial ratios

Data as of 11 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-56.8%-64.3%-100.6%-60.8%-11.0%5.3%
Net margin-60.6%-68.3%-104.6%-61.9%-11.6%4.7%
Return on equity-28.1%-23.1%-27.9%-14.6%-4.7%2.6%
Return on assets-13.8%-13.9%-18.1%-10.2%-2.9%1.8%
Free cash flow yield—2.8%3.4%9.8%26.1%14.2%
Revenue growth8.2%4.8%-10.9%-5.4%16.4%70.2%
Earnings growth-4.0%-31.6%50.5%404.8%-390.4%-114.2%
Current ratio0.70x1.11x1.46x3.03x1.66x1.36x
Debt to equity0.27x0.30x0.22x0.21x0.25x0.00x
Equity ratio49.0%60.1%64.9%69.7%60.7%69.1%
Interest coverage-12.49x-14.70x-24.10x-23.18x-33.73x40.92x
R&D as a share of sales10.3%11.4%11.6%19.7%12.4%7.0%
Buybacks as a share of market value—-0.2%-0.2%-33.9%-19.6%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue0.4%2.2%18.6%
Operating income-1.8%—11.6%
Net income-0.4%—15.0%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-61.2%-71.0%-48.0%-55.8%
Net margin-64.3%-73.1%-49.7%-55.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-14.6-19.1-10.8-17.0-64.7133.4-11.7-10.3-15.4-23.5
Price to sales8.813.111.310.57.56.26.513.49.118.6

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.